Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David J. Straus, MD
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Comprehensive Cancer Centers of the Desert
Palm Springs, California, United States
- Division of Oncology
Palo Alto, California, United States
- George Washington University Medical Center
Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Rush Cancer Institute
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- University of Texas - Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 1997
- Primary completion
- 30 Sept 2003
- Completion
- 30 Sept 2003
- Last update posted
- 3 Jul 2013
- Registered enrollment
- 275
- Registry id
- NCT00003341
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.